COVID-19-associated immune thrombocytopenia
| Autor: | Mara-Andrada Plesu, Gabriel Cristian Bejan, Ioana Veronica Grajdeanu, Anca Angela Simionescu, Ana Maria Alexandra Stanescu |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Romanian Journal of Infectious Diseases, Vol 24, Iss 2, Pp 63-70 (2021) |
| Druh dokumentu: | article |
| ISSN: | 1454-3389 2069-6051 |
| DOI: | 10.37897/RJID.2021.2.1 |
| Popis: | The coronavirus disease 2019 (COVID-19) is a contagious respiratory tract infection caused by the betacoronavirus SARS-CoV-2. The World Health Organization declared the COVID-19 outbreak a pandemic on March 11, 2020. Since the COVID-19 pandemic started, more than 166 million patients have been tested positive worldwide with more than 3.4 million related death recorded. COVID-19 has a wide range of signs and symptoms. Hematological changes such as lymphopenia, thrombocytopenia, and coagulation disturbances are not unusual in patients with COVID-19. However, the mechanisms causing these changes are partially comprehended. Immune thrombocytopenia was identified to be among the hematologic autoimmune diseases seen in patients infected with SARS-CoV-2. This review summarizes the evidence on COVID-19-associated immune thrombocytopenia and the underlying mechanisms involved in its development. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|